Literature DB >> 19729579

Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number.

Anna M Nelson1, Gaynor A Larson, Nancy R Zahniser.   

Abstract

Both humans and animals exhibit marked individual differences in cocaine responsiveness. By using the median split of cocaine-induced locomotor activity, we have classified outbred male Sprague-Dawley rats as either low or high cocaine responders (LCRs or HCRs, respectively). LCR/HCR classification predicts differences in cocaine inhibition of striatal dopamine (DA) transporters (DATs), cocaine-induced locomotor sensitization, cocaine-conditioned place preference, and motivation to self-administer cocaine. In this study, we used in vivo microdialysis to investigate whether the differential cocaine inhibition of DATs in LCRs and HCRs is translated into differential extracellular DA levels. Paralleling their locomotor profiles, LCRs and HCRS had similar basal extracellular DA levels in dorsal striatum (dSTR) and nucleus accumbens (NAc); after acute cocaine injection (10 mg/kg i.p.), HCRs showed greater cocaine-induced increases in DA than LCRs, with more pronounced differences in NAc. After repeated cocaine injection, LCRs and HCRs no longer differed in cocaine-induced locomotor activity or extracellular DA. To further explore the differential susceptibility of LCR/HCR DATs to cocaine, we used in vitro [(3)H]2-carbomethoxy-3-(4-fluorophenyl)tropane ([(3)H]WIN 35,428) binding and quantitative autoradiography to measure the number of DAT binding sites and cocaine's affinity for them. After acute cocaine administration, HCRs had fewer DAT binding sites in dSTR and NAc shell, compared to LCRs. No LCR/HCR differences were observed in DAT number after repeated cocaine injection or in cocaine's affinity. Our findings suggest that levels of striatal extracellular DA and DATs both make important contributions to initial differences in cocaine activation, which in LCRs/HCRs predict differential cocaine reward and reinforcement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729579      PMCID: PMC2784716          DOI: 10.1124/jpet.109.159897

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine.

Authors:  C L Duvauchelle; A Ikegami; E Castaneda
Journal:  Behav Neurosci       Date:  2000-12       Impact factor: 1.912

Review 2.  Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems.

Authors:  N R Zahniser; S Doolen
Journal:  Pharmacol Ther       Date:  2001-10       Impact factor: 12.310

3.  From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol.

Authors:  Fernando A Wagner; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2002-04       Impact factor: 7.853

4.  Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  1992-09       Impact factor: 4.030

Review 5.  Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.

Authors:  Y Zhang; T M Loonam; P A Noailles; J A Angulo
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

6.  Individual differences in cocaine-induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens.

Authors:  Jilla Sabeti; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

7.  Low level of response to alcohol as a predictor of future alcoholism.

Authors:  M A Schuckit
Journal:  Am J Psychiatry       Date:  1994-02       Impact factor: 18.112

8.  Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.

Authors:  Jilla Sabeti; Greg A Gerhardt; Nancy R Zahniser
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

9.  Dopamine transport function is elevated in cocaine users.

Authors:  Deborah C Mash; John Pablo; Qinjie Ouyang; W Lee Hearn; Sari Izenwasser
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

10.  Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter.

Authors:  Joshua M Gulley; Brian R Hoover; Gaynor A Larson; Nancy R Zahniser
Journal:  Neuropsychopharmacology       Date:  2003-12       Impact factor: 7.853

View more
  22 in total

1.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

2.  Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system.

Authors:  Fábio C Cruz; Marcelo Tadeu Marin; Rodrigo Molini Leão; Cleopatra S Planeta
Journal:  J Neural Transm (Vienna)       Date:  2011-10-18       Impact factor: 3.575

3.  Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter.

Authors:  Linda J Porrino; Mack D Miller; Hilary R Smith; Susan H Nader; Michael A Nader
Journal:  Biol Psychiatry       Date:  2016-02-23       Impact factor: 13.382

4.  Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression.

Authors:  XinJian Liu; Qian Huang; Fang Li; Chuan-Yuan Li
Journal:  Sci China Life Sci       Date:  2014-08-16       Impact factor: 6.038

5.  Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal.

Authors:  Katharine M Seip; Brian Reed; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

6.  Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats.

Authors:  Stanislav Koulchitsky; Benjamin De Backer; Etienne Quertemont; Corinne Charlier; Vincent Seutin
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

Review 7.  Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors.

Authors:  Dorothy J Yamamoto; Anna M Nelson; Bruce H Mandt; Gaynor A Larson; Jacki M Rorabaugh; Christopher M C Ng; Kelsey M Barcomb; Toni L Richards; Richard M Allen; Nancy R Zahniser
Journal:  Neurosci Biobehav Rev       Date:  2013-07-12       Impact factor: 8.989

8.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

9.  Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Authors:  Bruce H Mandt; Nancy R Zahniser
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

10.  Cocaine-induced locomotor activity in rats selectively bred for low and high voluntary running behavior.

Authors:  Jacob D Brown; Caroline L Green; Ian M Arthur; Frank W Booth; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2014-08-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.